Applications across research and diagnostics define the
His Tag Antibody Market value chain. Protein purification leads with a 2024 valuation of USD 640 million, projected to grow to USD 1,360 million by 2035. Western blotting follows as a critical detection method in cell biology and immunology research. Immunofluorescence integrates with advanced imaging technologies for clinical and research applications. ELISA continues serving quantitative protein and antibody detection needs.
Key market players include Thermo Fisher Scientific, Abcam, Merck KGaA's MilliporeSigma, GenScript, Cell Signaling Technology, Bio-Rad Laboratories, Promega Corporation, and QIAGEN. Recent strategic developments include Abcam's March 2025 collaboration with Thermo Fisher Scientific to co-develop enhanced anti-His tag antibodies. MilliporeSigma secured a major contract in June 2025 to supply antibodies for large-scale biopharmaceutical manufacturing. These partnerships and contract wins reflect intensifying competition and innovation in the market.
FAQ
Q1: What is the largest application segment? A: Protein purification dominates with a 2024 value of USD 640 million.
Q2: Who are the leading market players? A: Key players include Thermo Fisher Scientific, Abcam, Merck KGaA, and GenScript.
Q3: What recent collaboration occurred? A: Abcam and Thermo Fisher Scientific partnered in March 2025 to co-develop enhanced anti-His tag antibodies.
About SPORTIVO Network
Czech
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek